Left ventricular outflow tract obstruction and sudden death in hypertrophic cardiomyopathy [1]

European Heart Journal

Volumn 27, Issue 24, 2006, Pages 3073-

  Elliott, Perry ^a   Gimeno, Juan ^b   Tomé, Maite ^a   McKenna, William ^a  

^a UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^b HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR RISK; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; DISEASE ASSOCIATION; DISEASE SEVERITY; EVIDENCE BASED MEDICINE; FAMILY HISTORY; HEART LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; LETTER; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; PROPHYLAXIS; RISK ASSESSMENT; SUDDEN DEATH; SURVIVAL RATE; TREATMENT INDICATION; HEART OUTFLOW TRACT OBSTRUCTION; NOTE; RISK FACTOR;

CARDIOMYOPATHY, HYPERTROPHIC; DEATH, SUDDEN, CARDIAC; HUMANS; RISK FACTORS; VENTRICULAR OUTFLOW OBSTRUCTION;

EID: 33845661602     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehl383     Document Type: Letter

References (5)

1. Elliott PM, Gimeno JR, Tome MT, Shah J, Ward D, Thaman R, Mogensen J, McKenna WJ. Left ventricular outflow tract obstruction and sudden death risk in patients with hypertrophic cardiomyopathy. Eur Heart J. Published online ahead of print June 5 2006.
2. Maron BJ, Olivotto I, Maron MS. The dilemma of left ventricular outflow tract obstruction and sudden death in hypertrophic cardiomyopathy: do patients with gradients really deserve prophylactic defibrillators? Eur Heart J. Published online ahead of print July 3 2006.
3. Maron BJ, McKenna WJ, Danielson GK, Kappenberger LJ, Kuhn HJ, Seidman CE, Shah PM, Spencer WH III, Spirito P, Ten Cate FJ, Wigle ED; American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents; European Society of Cardiology Committee for Practice Guidelines. American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol 2003;42:1687-1713.
4. Elliott PM, Poloniecki J, Dickie S, Sharma S, Monserrat L, Varnava A, Mahon NG, McKenna WJ. Sudden death in hypertrophic cardiomyopathy: identification of high risk patients. J Am Coll Cardiol 2000;36:2212-2218.
5. Maron BJ, Spirito P, Haas TS, for the ICD in HCM Investigators. Efficacy of the implantable defibrillator for prevention of sudden death in hypertrophic cardiomyopathy: data from the international registry of 506 high risk patients (Abstract). Circulation 2005;112 (Suppl. II):531.